Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Ther Drug Monit. 2012 Aug;34(4):398–405. doi: 10.1097/FTD.0b013e31825c827a

Figure 3.

Figure 3

Polymyxin B1 and polymyxin B2 plasma concentration in time in a 27 year-old patient with cystic fibrosis receiving polymyxin B intravenously at a dose of 1.5 mg/kg/12h.